MONOTX Trademark

Trademark Overview


On Friday, December 7, 2018, a trademark application was filed for MONOTX with the United States Patent and Trademark Office. The USPTO has given the MONOTX trademark a serial number of 88221562. The federal status of this trademark filing is REGISTERED as of Tuesday, August 25, 2020. This trademark is owned by Mononuclear Therapeutics Limited. The MONOTX trademark is filed in the Transportation & Storage Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Storage and retrieval of blood, tissue and stem cells for medical research, treatment and diagnostics; storage and retrieval of blood and blood components for medical research; biomedical services namely, the storage of human cells, specifically umbilical cord blood, umbilical cord blood cells, and stem cells for medical use and research use

Collection and testing of cord blood, blood components, tissue and stem cells for medical research; medical diagnostic testing relating to cord blood, placenta tissue, human body

Research and development services in cellular therapy, in particularly, research and development in the field of treatment and medical diagnosis using cellular, molecular, biotechnological and genetic methods, and in the field of development of monuclear cell therapy; research and development of individualized medicine, development of treatment plan and therapy adapted for individual patients; biomedical laboratory services for others, namely, the collection, extraction, processing, cryopreservation, analysis, screening, testing, typing and storage of umbilical cord blood, placenta, human tissues and stem cells; genetic testing services for research purposes; consultation, research and development relating to scientific research; research and development relating to medicine and healthcare products; development of testing methods in the fields of cellular therapy
monotx

General Information


Serial Number88221562
Word MarkMONOTX
Filing DateFriday, December 7, 2018
Status700 - REGISTERED
Status DateTuesday, August 25, 2020
Registration Number6137042
Registration DateTuesday, August 25, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2019

Trademark Statements


Goods and ServicesStorage and retrieval of blood, tissue and stem cells for medical research, treatment and diagnostics; storage and retrieval of blood and blood components for medical research; biomedical services namely, the storage of human cells, specifically umbilical cord blood, umbilical cord blood cells, and stem cells for medical use and research use
Goods and ServicesCollection and testing of cord blood, blood components, tissue and stem cells for medical research; medical diagnostic testing relating to cord blood, placenta tissue, human body
Goods and ServicesResearch and development services in cellular therapy, in particularly, research and development in the field of treatment and medical diagnosis using cellular, molecular, biotechnological and genetic methods, and in the field of development of monuclear cell therapy; research and development of individualized medicine, development of treatment plan and therapy adapted for individual patients; biomedical laboratory services for others, namely, the collection, extraction, processing, cryopreservation, analysis, screening, testing, typing and storage of umbilical cord blood, placenta, human tissues and stem cells; genetic testing services for research purposes; consultation, research and development relating to scientific research; research and development relating to medicine and healthcare products; development of testing methods in the fields of cellular therapy

Classification Information


International Class039 - Transport; packaging and storage of goods; travel arrangement.
US Class Codes100, 105
Class Status Code6 - Active
Class Status DateMonday, December 31, 2018
Primary Code039
First Use Anywhere DateFriday, November 1, 2019
First Use In Commerce DateFriday, November 1, 2019

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 31, 2018
Primary Code042
First Use Anywhere DateFriday, November 1, 2019
First Use In Commerce DateFriday, November 1, 2019

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 9, 2019
Primary Code044
First Use Anywhere DateFriday, November 1, 2019
First Use In Commerce DateFriday, November 1, 2019

Trademark Owner History


Party NameMononuclear Therapeutics Limited
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressShatin NT
HK

Party NameMononuclear Therapeutics Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressShatin NT
HK

Party NameMononuclear Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressShatin NT
HK

Trademark Events


Event DateEvent Description
Monday, December 31, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 11, 2018NEW APPLICATION ENTERED
Wednesday, March 13, 2019NON-FINAL ACTION WRITTEN
Tuesday, September 10, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 25, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 6, 2019ASSIGNED TO EXAMINER
Wednesday, March 13, 2019NON-FINAL ACTION E-MAILED
Wednesday, March 13, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, September 8, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 9, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, September 8, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 12, 2019ASSIGNED TO LIE
Wednesday, January 29, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 10, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, June 30, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 25, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 25, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 15, 2019PUBLISHED FOR OPPOSITION
Tuesday, October 15, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 10, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 29, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 10, 2020USE AMENDMENT FILED
Tuesday, June 30, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 22, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, July 23, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 25, 2020REGISTERED-PRINCIPAL REGISTER
Thursday, December 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 25, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, December 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED